Gunter Heimann

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Randomization and allocation procedures for master protocol trials of single-arm studies.

Randomization and allocation procedures for master protocol trials of single-arm studies.

Journal: Statistical methods in medical research

Published: March 25, 2026

Concentration response analyses for QT data with several active compounds.

Concentration response analyses for QT data with several active compounds.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: May 18, 2025

Using Confidence Distributions in Final and Interim Analyses for Single-Arm Studies or Platform Trials Consisting of Single-Arm Studies.

Using Confidence Distributions in Final and Interim Analyses for Single-Arm Studies or Platform Trials Consisting of Single-Arm Studies.

Journal: Statistics in medicine

Published: December 19, 2024

A note on phase I interleaved versus parallel group ascending dose designs for concentration-QTc analyses.

A note on phase I interleaved versus parallel group ascending dose designs for concentration-QTc analyses.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: November 06, 2024

Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.

Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.

Journal: Neuro-oncology practice

Published: July 15, 2024

Lessons learned from drug trials in neurofibromatosis: A systematic review.

Lessons learned from drug trials in neurofibromatosis: A systematic review.

Journal: European journal of medical genetics

Published: March 29, 2021

Exposure-response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimus.

Exposure-response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimus.

Journal: CPT: pharmacometrics & systems pharmacology

Published: November 17, 2020

Identifying challenges in neurofibromatosis: a modified Delphi procedure.

Identifying challenges in neurofibromatosis: a modified Delphi procedure.

Journal: European journal of human genetics : EJHG

Published: October 15, 2020

Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidates.

Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidates.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: May 16, 2018

A nonparametric method to detect increased frequencies of adverse drug reactions over time.

A nonparametric method to detect increased frequencies of adverse drug reactions over time.

Journal: Statistics in medicine

Published: September 20, 2016

Model averaging for robust assessment of QT prolongation by concentration-response analysis.

Model averaging for robust assessment of QT prolongation by concentration-response analysis.

Journal: Statistics in medicine

Published: June 30, 2016

Exact and asymptotic inference in clinical trials with small event rates under inverse sampling.

Exact and asymptotic inference in clinical trials with small event rates under inverse sampling.

Journal: Statistics in medicine

Published: September 12, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026